Mixture Sciences, Inc., a privately-held biotechnology company, specializes in biomedical research and drug discovery. We use a combination of proprietary and in-licensed technologies for the discovery of therapeutic and diagnostic candidates for the treatment of HIV/AIDS, cancer, diabetes, multiple sclerosis, and infectious diseases, including Lyme Disease. Our technologies have been validated and used by members of the academic and corporate community over the past decade.

Our success comes from being a worldwide leader in the use of mixture-based chemical libraries. Our unique position allows us to provide our collaborators exceptional technologies and expertise. Mixture Sciences, Inc. is committed to developing, improving, patenting and in-licensing new technologies in order to provide our collaborators with the most cost efficient methods for identifying ligands.